Niitaka
4465.TChemicals
Financials · Consolidated
| Fiscal year ended | 2026-05 | 2025-05 | 2024-05 | 2023-05 | 2022-05 | 2021-05 |
|---|---|---|---|---|---|---|
| Revenue | ¥24.6bn | ¥23.7bn | ¥22.7bn | ¥19.5bn | ¥17.8bn | ¥18.4bn |
| Operating income | ¥2.1bn | ¥1.9bn | ¥1.5bn | ¥855m | ¥1.8bn | ¥2.4bn |
| Ordinary income | ¥2.2bn | ¥2.0bn | ¥1.5bn | ¥887m | ¥1.9bn | ¥2.5bn |
| Net income (owners) | ¥1.9bn | ¥1.8bn | ¥706m | ¥562m | ¥1.2bn | ¥697m |
| Total assets | ¥23.8bn | ¥22.6bn | ¥22.7bn | ¥23.6bnr | ¥20.8bn | ¥20.5bn |
| Net assets / equity | ¥16.3bn | ¥14.8bn | ¥13.4bn | ¥13.0bnr | ¥12.5bn | ¥11.3bn |
| Operating cash flow | ¥2.7bn | ¥1.0bn | ¥1.3bn | ¥1.1bn | ¥1.6bn | ¥2.7bn |
| EPS (basic) | ¥321.01 | ¥305.84 | ¥119.58 | ¥95.13 | ¥208.59 | ¥118.11 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 7
| Period | Form | Figures |
|---|---|---|
| 2025-06-01 → 2026-05-31 | AnnualAmended | 202 figures · EDINET |
| 2025-06-01 → 2026-05-31 | Annual | 202 figures · EDINET |
| 2024-06-01 → 2025-05-31 | Annual | 202 figures · EDINET |
| 2023-06-01 → 2024-05-31 | Annual | 202 figures · EDINET |
| 2022-06-01 → 2023-05-31 | Annual | 196 figures · EDINET |
| 2021-06-01 → 2022-05-31 | AnnualAmended | 196 figures · EDINET |
| 2021-06-01 → 2022-05-31 | Annual | 196 figures · EDINET |
25 more reports are still being processed.
Segments · FY ended 2026-05
| Segment | External sales | Profit |
|---|---|---|
| Chemical Business | ¥23.3bn | ¥1.9bn |
| Healthcare Business | ¥1.4bn | ¥212m |
| Total | ¥24.6bn | ¥2.1bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.